Eva Schaden

Effect of thromboelastography (TEG®) and rotational thromboelastometry (ROTEM®) on diagnosis of coagulopathy, transfusion guidance and mortality in trauma: descriptive systematic review

Endogenous thrombin potential following hemostatic therapy with 4-factor prothrombin complex concentrate: a 7-day observational study of trauma patients

Fibrinogen levels in trauma patients during the first seven days after fibrinogen concentrate therapy: a retrospective study

The use of viscoelastic haemostatic assays in goal-directing treatment with allogeneic blood products – A systematic review and meta-analysis

Circulating mitochondrial DAMPs cause inflammatory responses to injury

Targeted Thromboelastographic (TEG) Blood Component and Pharmacologic Hemostatic Therapy in Traumatic and Acquired Coagulopathy

Global epidemiology and outcomes of acute kidney injury

Specialized nutritional support interventions in critically ill patients on renal replacement therapy

Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient

Is Dilutional Coagulopathy Induced by Different Colloids Reversible by Replacement of Fibrinogen and Factor XIII Concentrates?

Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient

PRECLINICAL MODELS OF TRAUMATIC, HEMORRHAGIC SHOCK

The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition

Impact of rivaroxaban on point-of-care assays

The obesity paradox in surgical intensive care unit patients

The Relationship Among Obesity, Nutritional Status, and Mortality in the Critically Ill*

Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding

Acute kidney injury in patients with severe sepsis in Finnish Intensive Care Units

Intracranial pressure-alterations during controlled intramedullary reaming of femoral fractures: an animal study

Measuring the activity of apixaban and rivaroxaban with rotational thrombelastometry

Fibrinogen function after severe burn injury

Determination of enoxaparin with rotational thrombelastometry using the prothrombinase-induced clotting time reagent

Perioperative treatment algorithm for bleeding burn patients reduces allogeneic blood product requirements

Ecarin modified rotational thrombelastometry: a point-of-care applicable alternative to monitor the direct thrombin inhibitor argatroban

Effect of the carrier solution for hydroxyethyl starch on platelet aggregation and clot formation

Impact of body mass on incidence and prognosis of acute kidney injury requiring renal replacement therapy